Despite similar enzymatic activity, SMS1 and SMS2 have a divergent influence on glioma patients’ overall survival, and this divergence is possibly associated with the different roles in cancer (and possibly normal) cell differentiation, proliferation and survival. The gene discussed is SGMS1; the disease is glioma.